| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > The Manager's Path to PR Quality |
|
Just Other Articles - The Manager's Path to PR Quality
What is it, you might ask, that allows certain business,
non-profit, government agency or association managers
to believe that they run a high-quality public relations
operation? In my judgement, they can believe that only if: 1) They operate a strategic PR plan that leads directly to achieving their unit’s managerial objectives. 2) They do something really significant about those important outside audience behaviors that MOST According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product affect the department, group, division or subsidiary
unit they manage. 3) They take advantage of the perception levels they’ve achieved as those key external audiences become persuaded to the manager’s way of thinking. 4) And once having persuaded many members of that key external audience to their views on the issue in question, watch that perception closely as it usually morphs into behavioral actions that allow their unit to ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in succeed. But few managers achieve this level without earlier exposure to the tactical approach to public relations. An approach that pretty much uses a collection of communications tactics to move a message from one point to another. And that’s fine if the manager’s only objective is to create print and broadcast exposure. However, problems arise when it becomes obvious that counterproductive behaviors by target audiences are the dire lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ct
result of negative perceptions about the organization or its
services, products or personnel. Suddenly, it is clear why steps must be taken to monitor opinion among members of your most important outside audiences to (1) determine how they perceive your organization; (2) to further evaluate those survey results in order to identify and prioritize public relations goals; (3) to create and share corrective messages with key outside a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe diences and, finally,
(4) to carefully monitor how and when those perceptions
inevitably become the key audience behaviors you know you
need as the manager in charge of your unit. This is an action plan that calls on you to do some meaningful things about the behaviors of those important outside audiences that most affect your operation; to create the kind of external stakeholder behavior change that leads directly to achieving your m d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro anagerial objectives; and to do so by persuading those
key outside folks to your views by helping move them to take
actions that allow your department, group, division or subsidiary
to succeed. Still, you may be wondering, what’s REALLY going on here? Well, you’re preparing to do something positive about the behaviors of the very outside audiences of yours that MOST affect your operation. And that’s when PR can actually create the kin ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d of external stakeholder behavior change that leads
directly to achieving those key managerial objectives of yours. By the way, the foundational premise for this approach to the practice of public relations is sound: people act on their own perception of the facts before them, which leads to predictable behaviors about which something can be done. When we create, change or reinforce that opinion by reaching, persuading and moving-to-d easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi esired-action the very people whose behaviors
affect the organization the most, the public relations mission
is accomplished. Conducting public relations this way, a manager might expect results along these lines: new proposals for strategic alliances and joint ventures; a rebound in showroom visits; customers making repeat purchases; improved relations with government agencies and legislative bodies; membership applications on the ri nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e; capital givers or specifying sources looking your way;
fresh community service and sponsorship opportunities;
prospects starting to work with you and even stronger
relationships with the educational, labor, financial and healthcare communities. It pays to review your PR timeline with your PR staff and, moreover, take the time to critique how you will monitor and gather perceptions by questioning members of your most important outsid and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e audiences. Suggest queries along these lines:
how much do you know about our organization? Have you had
prior contact with us and were you pleased with the exchange?
Are you familiar with our services or products and employees?
Have you experienced problems with our people or procedures? Are you confident that your most dependable and professional PR people really accept why it’s SO important to know how your most important outside a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi udiences perceive your operations,
products or services? And do you believe THEY believe that
perceptions almost always result in behaviors that can help or
hurt your operation? Of course, any kind of surveying/polling and the like usually go easier when a professional survey firm helps monitor your key audience’s perceptions. But real pros cost real money compared to using your existing public relations staff who, while they are alre ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ady in the perception and behavior business,
also cost money. But whether it’s your people or a survey firm
asking the questions, the objective remains the same: identify
untruths, false assumptions, unfounded rumors, inaccuracies,
misconception and any other negative perception that might
translate into hurtful behaviors. This is the time to set a realistic PR goal, one that calls for action on the most serious problem areas you uncov dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod red
during your key audience perception monitoring. You may,
for example, decide to straighten out that dangerous
misconception, bring to an end that potentially painful rumor,
or correct that terrible inaccuracy. Your new goal, obviously will get you nowhere without the support of an action-oriented strategy. If, that is, you are to know how to get to where you’re going. And do keep in mind that you have just three strategic options cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin available to you when
it comes to doing something about perception and opinion:
change existing perception, create perception where there may
be none, or reinforce it. Needless to say, the wrong strategy
pick will taste like chocolate chips in your liverwurst soup.
So be sure your new strategy fits well with your new public
relations goal. You certainly don’t want to pursue “change”
when the facts dictate a strategy of reinforcement. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Now, in order to move your key audience to your way of
thinking, the best writer on your team must prepare a carefully
-written message targeted directly at your key external audience.
And make no mistake about it, putting together a really
persuasive message usually is the toughest part of this drill.
S/he must produce some really corrective language that is not
merely compelling, persuasive and believable, but clear and
factual if th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ey are to shift perception/opinion towards your
point of view and lead to the behaviors you have in mind. To carry your message to the attention of your target audience, you’ll require carefully selected communications tactics and there are many such available. From speeches, facility tours, emails and brochures to consumer briefings, media interviews, newsletters, personal meetings and many others. But be certain that the tactics you ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust pick are known to reach folks just
like your audience members. As the program gets under way, you’ll probably want to unveil your corrective message before smaller meetings rather than using higher profile news releases or broadcast announcements. Reason is, a message’s credibility is always fragile and often suspect, depending on the method by which it is delivered, The time needed to prepare and distribute progress reports is time w y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ell invested because you will be illustrating how the
monies spent on public relations can pay off. But they’ll also
be your alert to start a second perception monitoring session
with members of your external audience. Here, you’ll use
many of the same questions used in the benchmark interviews.
Only difference now is, you will be on strict alert for signs
that the bad news perception is being altered in your direction. In the unlikely . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de event that forward motion slows down a bit, be
advised that you can always add more communications tactics,
and/or increase their frequencies to address that problem. In one long sentence, the manager’s path to quality public relations requires that you resolve to do something about the behaviors of those outside audiences that most affect your operation; create the kind of external stakeholder behavior change that leads directly to a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip chieving your managerial
objectives; and do so by persuading those key outside folks
to your way of thinking by helping move them to take actions
that allow your department, group, division or subsidiary
unit to succeed. Robert A. Kelly © 2006 Please feel free to publish this article and resource box in your ezine, newsletter, offline publication or website. Only requirements: you must use the Robert A. Kelly byline, and resource box tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How Do You Define a Good Logo Design? How to Motivate Under-Performing Personnel Investor Awareness Campaigns: A Look at the Other Side
|